South India led India's bioeconomy, contributing 45.4% ($75.2 billion), with Maharashtra, Karnataka, and Telangana emerging ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands ...

India's bio-economy has witnessed an extraordinary 16-fold surge over the past decade, growing from $10 billion in 2014 to an ...

If we get this right, we can make a powerful positive case for the biotech revolution—reducing the potential for a backlash, and ensuring that consumers, regulators, and other stakeholders ...

The R.I. Life Science Hub is leading development of our state’s first life science incubator, and is already generating a great return on our investment, writes House Speaker K. Joseph Shekarchi ...

Agenus Chief Medical Officer Dr. Steven O'Day joined Fierce's Chris Hayden on a recent sponsored episode of The Top Line ...

Science and Technology Minister Jitendra Singh Friday called for bigger investments from the private sector in the bio-economy domain which, he said, has witnessed a 16-fold rise over the past decade.

This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw ...

and his central role in the birth and proliferation of the biotechnology industry. His 1977 discovery of RNA splicing set the stage for a revolution in molecular biology, enabling research into a ...

Yet core facility operators contend they have a role to play in the biotech market, saying that their higher prices are offset by better service and quality control. Today's DNA synthesizers are ...

Jan. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines ... in a fireside chat as part of the Guggenheim Securities SMID Cap Biotech Conference on Wednesday, February 5, 2025, at 10:30 a.m ...